Feasibility of a New Technology for Isolating Circulating Tumour Cells

Clinical trial NCT03979339 · UNKNOWN

Trial details

NCT number: NCT03979339
Sponsor: Centre Oscar Lambret
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

HER2-positive Metastatic Breast Cancer Ovarian Cancer Hormone-resistant Prostate Cancer Circulating Tumor Cell

Start date: 2020-03-11
Primary completion: 2022-12-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.